Omvoh 100 mg + 200 mg
As listed in the register: Omvoh 100 mg + 200 mg, solution injectable en seringue préremplie
100 mg + 200 mg ·
- Prescription only
- Cancer treatments and immune-system medicines
- Active substance
- Mirikizumabum
- Made by
- Eli Lilly (Suisse) SA
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Colite ulcéreuse, Maladie de Crohn
From the official label · 2026-09-30 · Swissmedic
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
SpainNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
Details
| Made by | Eli Lilly (Suisse) SA |
|---|---|
| Active substance | Mirikizumabum |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 100 mg + 200 mg |
| Classification | L04AC24 · Cancer treatments and immune-system medicines |
| Dispensing (as stated by the register) | Abgabekategorie B |
| Name in the register | Omvoh 100 mg + 200 mg, solution injectable en seringue préremplie |
| Packs | 1 + 1 Fertigspritze(n) |
| Zulassungsnummer | 68951 |
| Dosisstärke | 2 |
Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician
Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.
Other strengths and forms
2 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- 2 products
100 mg + 200 mg2
100 mg + 200 mg · 2 companies
- Eli Lilly (Suisse) SA · this page
- Eli Lilly (Suisse) SA
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.